Total Payments
$110,907
2024 Payments
$15,831
Companies
39
Transactions
1,997
Medicare Patients
3,529
Medicare Billing
$597,468
Payment Breakdown by Category
Other$85,731 (77.3%)
Food & Beverage$23,944 (21.6%)
Travel$1,174 (1.1%)
Education$40.98 (0.0%)
Consulting$16.11 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $85,731 | 63 | 77.3% |
| Food and Beverage | $23,944 | 1,924 | 21.6% |
| Travel and Lodging | $1,174 | 3 | 1.1% |
| Education | $40.98 | 6 | 0.0% |
| Consulting Fee | $16.11 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $38,983 | 427 | $0 (2024) |
| Allergan, Inc. | $27,794 | 136 | $0 (2020) |
| NESTLE HEALTHCARE NUTRITION INC. | $19,970 | 73 | $0 (2023) |
| AIMMUNE THERAPEUTICS, INC. | $7,927 | 31 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $4,929 | 436 | $0 (2024) |
| QOL Medical, LLC | $2,314 | 199 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $1,533 | 118 | $0 (2024) |
| Gilead Sciences, Inc. | $797.49 | 82 | $0 (2023) |
| Janssen Biotech, Inc. | $733.81 | 53 | $0 (2024) |
| IRONWOOD PHARMACEUTICALS, INC | $724.32 | 64 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $15,831 | 258 | AIMMUNE THERAPEUTICS, INC. ($7,927) |
| 2023 | $19,099 | 252 | ABBVIE INC. ($9,619) |
| 2022 | $18,288 | 337 | ABBVIE INC. ($10,550) |
| 2021 | $14,797 | 284 | AbbVie Inc. ($6,449) |
| 2020 | $7,081 | 185 | Allergan, Inc. ($2,532) |
| 2019 | $13,600 | 322 | Allergan Inc. ($10,958) |
| 2018 | $9,600 | 219 | Allergan Inc. ($7,806) |
| 2017 | $12,612 | 140 | Allergan Inc. ($6,497) |
All Payment Transactions
1,997 individual payment records from CMS Open Payments — Page 1 of 80
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/18/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.35 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $8.01 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $6.26 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $10.50 | General |
| Category: Immunology | ||||||
| 12/06/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $22.16 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $18.30 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/04/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $5.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $4.36 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/20/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: LIVER DISEASE | ||||||
| 11/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: Immunology | ||||||
| 11/19/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $20.59 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/13/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 951 | 1,184 | $378,875 | $164,754 |
| 2022 | 10 | 876 | 1,120 | $363,450 | $159,033 |
| 2021 | 10 | 865 | 1,148 | $361,405 | $159,133 |
| 2020 | 13 | 837 | 1,032 | $265,543 | $114,548 |
Total Patients
3,529
Total Services
4,484
Medicare Billing
$597,468
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 338 | 560 | $75,600 | $54,629 | 72.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2023 | 51 | 51 | $35,700 | $17,188 | 48.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 48 | 48 | $31,200 | $14,120 | 45.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 32 | 32 | $30,400 | $13,363 | 44.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 33 | 33 | $24,750 | $11,613 | 46.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2023 | 32 | 32 | $22,400 | $10,637 | 47.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $15,750 | $7,987 | 50.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 120 | $10,800 | $7,383 | 68.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $13,825 | $6,876 | 49.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 75 | 75 | $48,750 | $5,667 | 11.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $26,250 | $4,614 | 17.6% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 17 | 17 | $16,150 | $3,777 | 23.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 16 | 16 | $11,200 | $3,065 | 27.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 12 | 12 | $8,400 | $2,303 | 27.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 11 | 11 | $7,700 | $1,533 | 19.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 337 | 578 | $78,030 | $58,395 | 74.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 47 | 47 | $30,550 | $15,089 | 49.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 40 | 40 | $30,000 | $13,841 | 46.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Office | 2022 | 38 | 38 | $26,600 | $13,438 | 50.5% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Office | 2022 | 26 | 26 | $18,200 | $9,482 | 52.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 61 | 61 | $15,250 | $7,298 | 47.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 15 | 15 | $14,250 | $6,329 | 44.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 40 | 40 | $30,000 | $5,799 | 19.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 71 | 71 | $46,150 | $5,303 | 11.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 54 | 54 | $9,450 | $4,708 | 49.8% |
About Dr. Beth Gardner, MD
Dr. Beth Gardner, MD is a Gastroenterology healthcare provider based in Philadelphia, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1457334369.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beth Gardner, MD has received a total of $110,907 in payments from pharmaceutical and medical device companies, with $15,831 received in 2024. These payments were reported across 1,997 transactions from 39 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($85,731).
As a Medicare-enrolled provider, Gardner has provided services to 3,529 Medicare beneficiaries, totaling 4,484 services with total Medicare billing of $597,468. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Philadelphia, PA
- Active Since 11/23/2005
- Last Updated 02/09/2017
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1457334369
Products in Payments
- ZENPEP (Drug) $42,265
- LINZESS (Drug) $40,314
- CREON (Drug) $4,267
- XIFAXAN (Drug) $3,808
- Creon (Drug) $2,671
- Sucraid (Drug) $1,753
- VIBERZI (Drug) $956.41
- TRULANCE (Drug) $669.87
- ENTYVIO (Biological) $666.66
- Linzess (Drug) $653.82
- HUMIRA (Biological) $620.61
- ZEPOSIA (Drug) $610.06
- STELARA (Biological) $594.69
- SUCRAID (Drug) $560.74
- XIFAXANIBSD (Drug) $500.30
- IBSRELA (Drug) $490.14
- RINVOQ (Biological) $485.93
- Cimzia (Drug) $403.30
- Humira (Biological) $385.39
- Trulance (Drug) $376.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Philadelphia
Xiaoli Ma, Md, MD
Gastroenterology — Payments: $717,441
Gastroenterology $717,441
Gary Lichtenstein, Md, MD
Gastroenterology — Payments: $416,696
Gastroenterology $416,696
Dr. Neilanjan Nandi, Md, MD
Gastroenterology — Payments: $334,815
Gastroenterology $334,815
Dr. David Lichtenstein, M.d, M.D
Gastroenterology — Payments: $263,694
Gastroenterology $263,694
James Lewis, Md, MD
Gastroenterology — Payments: $229,188
Gastroenterology $229,188
Mark Osterman, Md, MD
Gastroenterology — Payments: $142,430
Gastroenterology $142,430